Results 221 to 230 of about 424,556 (264)

Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade

Cancer Cell, 2020
Robert Motzer, Thomas Powles, Mahrukh Huseni   +2 more
exaly  

Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer

Cancer Cell, 2021
Zhihua Liu, Tianyi Qian, Yuanyuan Zhang   +2 more
exaly  

Adrenergic blockade

American Heart Journal, 1960
openaire   +2 more sources

Blockade

2018
L. A. Atherley-Jones, Hugh H. L. Bellot
openaire   +2 more sources

Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade

Cell, 2018
Jedd Wolchok, F Stephen Hódi, Bastian Schilling   +2 more
exaly  

Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer

Annals of Oncology, 2019
Hye Ryun Kim, Beung-Chul Ahn, Hyo Sup Shim   +2 more
exaly  

Non-conventional Inhibitory CD4+Foxp3−PD-1hi T Cells as a Biomarker of Immune Checkpoint Blockade Activity

Cancer Cell, 2018
Jedd Wolchok, Alexander C Huang, Taha Merghoub   +2 more
exaly  

Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies

Cancer Cell, 2018
Jedd Wolchok, Taha Merghoub, Roberta Zappasodi   +2 more
exaly  

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Cancer Cell, 2020
John Haanen, Katie Campbell, Jedd Wolchok   +2 more
exaly  

Between blockade and counter-blockade

1941
openaire   +1 more source